Amarin Corp Plc (AMRN)

[Greymatter1]

And lets get back to reality, there are many obstacles to overcome here, almost too many too list. The 1A issue needs to be resolved but delays are abound. The medical community has been slow (I'm being kind) to embrace this product and all of it's benefits. Except for a few prescribers, doctors think of this as fish oil and nothing more. Script growth has been improving slowly and in very small increments, nothing that we as stakeholders will even see $10/share on. Will RI change that? Who knows. For those of you that think it's a sure thing, think again. RI will have to be overwhelmingly successful to change doctors thinking on this subject. Otherwise,doctors are likely just to continue management with statins alone. Early stoppage of RI is unlikely and not a good idea if that is the data the doctors are waiting for, however the longer the trial goes the lower the success rate is likely to be. Those touting the anti-inflammatory benefits will also need to wait for the scientific proof of it, which would be after RI, which puts that time frame out to about 2025. The stock has languished between 1.50-2.25 for over a year now, much to day traders delight because it has been so predictable. Other than the day traders and the people on this board, nobody else is giving this company much thought. To think this is such a game changer: a commodity play, or the best selling drug of all time, is really just hogwash. The people who bought at .80 are likely to see a small return from this, the people who bought at $10 may never see their money again. For those of you optimists what is your time frame: are you ok waiting until 2020 to get to $8/share?